Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kamada Ltd. - Ordinary Shares (NQ:KMDA)

6.660 +0.040 (+0.60%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Kamada Ltd. - Ordinary Shares

< Previous 1 2 3 Next >
An Overview of Kamada's Earnings
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
KAMADA LTD (NASDAQ:KMDA) Reports Mixed Q2 2025 Earnings with Strong EPS Beat and Raised Profitability Guidance
Kamada Ltd (KMDA) reported mixed Q2 2025 earnings, with revenue slightly below estimates but EPS beating forecasts. Stock rose pre-market as profitability outlook improved. 
Via Chartmill
Kamada Q1 Results: Double-Digit Growth, Company Reiterates Guidance As It Hits Multiple Milestones Including Plasma Business Expansion
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Kamada Q1 Results: Double-Digit Growth, Company Reiterates Guidance As It Hits Multiple Milestones Including Plasma Business Expansion
Via TheNewswire.com
Earnings Preview For Kamada
 
Via Benzinga
Earnings Scheduled For November 13, 2024
 
Via Benzinga
What's Next: Kamada's Earnings Preview
 
Via Benzinga
Earnings Scheduled For August 13, 2025
 
Via Benzinga
An Overview of Kamada's Earnings
 
Via Benzinga
Kamada Wants To Do More For Organ Transplant Patients, Increases Efforts To Build Awareness Of Its CMV Treatment CYTOGAM
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Kamada Wants To Do More For Organ Transplant Patients, Increases Efforts To Build Awareness Of Its CMV Treatment CYTOGAM
Via TheNewswire.com
Kamada Expects Third Plasma Collection Site To Support Its Hyper-Immune Plasma Needs And Add Up To $10M In Annual Revenue At Full Capacity
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Earnings Scheduled For May 14, 2025
 
Via Benzinga
Kamada Expects Third Plasma Collection Site To Support Its Hyper-Immune Plasma Needs And Add Up To $10M In Annual Revenue At Full Capacity
By Meg Flippin Benzinga 
Via TheNewswire.com
Kamada Is Bringing Relief To Those With Rare And Serious Conditions
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Kamada Is Bringing Relief To Those With Rare And Serious Conditions
Via TheNewswire.com
Sidoti Events, LLC's Virtual March Small-Cap Conference
Via ACCESS Newswire
Incyte, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session
 
Via Benzinga
Kamada Announces Dividend After Record-Breaking Year, Anticipates Further Double-Digit Growth
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Kamada Announces Dividend After Record-Breaking Year, Anticipates Further Double-Digit Growth
By JE Insights, Benzinga 
Via TheNewswire.com
How Kamada (NASDAQ: KMDA) Is Transforming Its Strategic Focus Into Commercial Growth
By JE Insights, Benzinga 
Via TheNewswire.com
Earnings Scheduled For March 5, 2025
 
Via Benzinga
How Kamada (NASDAQ: KMDA) Is Transforming Its Strategic Focus Into Commercial Growth
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
KMDA Stock Earnings: Kamada Beats EPS, Beats Revenue for Q2 2024
KMDA stock results show that Kamada beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Wednesday and we have all of the biggest stories traders need to know about this morning! 
Via InvestorPlace
3 Promising Biotech Stocks You Can Pick Up for Less Than $10
Healthcare innovations are big business. That said, biotech stocks under $10 may offer a higher ceiling thanks to their low price. 
Via InvestorPlace
KMDA Stock Earnings: Kamada Misses EPS, Misses Revenue for Q1 2024
KMDA stock results show that Kamada missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
KMDA Stock Earnings: Kamada Beats EPS, Misses Revenue for Q4 2023
KMDA stock results show that Kamada beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Earnings Scheduled For March 6, 2024
Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million. 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.